Source: Zacks

Thermo Fisher Scientific: Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings

Strength in Analytical Instruments and Specialty Diagnostics segments is likely to have driven Thermo Fisher's first-quarter 2025 performance.

Read full article »
Annual Revenue
$10-50B
Employees
100K-9.9M
Marc N. Casper's photo - Chairman & CEO of Thermo Fisher Scientific

Chairman & CEO

Marc N. Casper

CEO Approval Rating

91/100

Read more